(Q51562803)

7 April 2018

title

The beta2-adrenergic modulator celiprolol reduces insulin resistance in obese Zucker rats. (English)

1 reference

7 April 2018

0 references

1 reference

1 reference

Jacob S

1

1 reference

7 April 2018

Fogt DL

series ordinal

2

1 reference

7 April 2018

Dietze GJ

series ordinal

3

1 reference

7 April 2018

Henriksen EJ

series ordinal

4

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

7 April 2018

published in

Life Sciences

1 reference

7 April 2018

volume

64

1 reference

7 April 2018

issue

22

1 reference

7 April 2018

page(s)

2071-2079

1 reference

7 April 2018

Insulin sensitivity and blood lipids during antihypertensive treatment with special reference to ACE inhibition

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

Insulin sensitivity in a long-term crossover trial with celiprolol and other antihypertensive agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

Effect of soleus unweighting on stimulation of insulin-independent glucose transport activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900154-X

10.1016/S0024-3205(99)00154-X

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018